|
(Health-NewsWire.Net, April 08, 2015 ) Dallas, TX -- Global Markets Direct’s, ‘Encephalomyelitis – Pipeline Review, H1 2015′, provides an overview of the Encephalomyelitis’s therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Encephalomyelitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Encephalomyelitis and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Order a Purchase copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=328265 . (This is a premium report priced at US$2000 for a single user License.)
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
Table of Contents:
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Encephalomyelitis Overview 6
Therapeutics Development 7
Pipeline Products for Encephalomyelitis - Overview 7
Pipeline Products for Encephalomyelitis - Comparative Analysis 8
Encephalomyelitis - Therapeutics under Development by Companies 9
Encephalomyelitis - Therapeutics under Investigation by Universities/Institutes 10
Encephalomyelitis - Pipeline Products Glance 11
Clinical Stage Products 11
Early Stage Products 12
Encephalomyelitis - Products under Development by Companies 13
Encephalomyelitis - Products under Investigation by Universities/Institutes 14
Encephalomyelitis - Companies Involved in Therapeutics Development 15
Effimune SAS 15
Inquire for discount at http://www.rnrmarketresearch.com/contacts/discount?rname=328265 .
Scope:
• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in the therapeutics development for Encephalomyelitis and enlists all their major and minor projects.
• The report summarizes all the dormant and discontinued pipeline projects
• A review of the Encephalomyelitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
• A detailed assessment of monotherapy and combination therapy pipeline projects
• The report provides a snapshot of the global therapeutic landscape of Encephalomyelitis.
Reasons to Buy:
• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies.
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Develop strategic initiatives by understanding the focus areas of leading companies
• Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
• Devise corrective measures for pipeline projects by understanding Encephalomyelitis pipeline depth and focus of Indication therapeutics.
Explore more reports on Pharmaceuticals at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals .
About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
RnR Market Research
Ritesh Tiwari
+ 1-888-391-5441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
|
